California Public Employees Retirement System’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.52M Buy
116,107
+3
+0% +$158 ﹤0.01% 1015
2025
Q4
$6.09M Buy
116,104
+6,732
+6% +$403K ﹤0.01% 1014
2025
Q3
$7.09M Buy
109,372
+5,744
+6% +$330K ﹤0.01% 997
2025
Q2
$5.04M Buy
103,628
+8,011
+8% +$310K ﹤0.01% 1037
2025
Q1
$3.25M Sell
95,617
-331
-0.3% -$14K ﹤0.01% 1086
2024
Q4
$3.78M Sell
95,948
-10,908
-10% -$515K ﹤0.01% 1100
2024
Q3
$5.02M Sell
106,856
-36,284
-25% -$1.84M ﹤0.01% 1087
2024
Q2
$7.73M Buy
143,140
+35,411
+33% +$2.05M 0.01% 961
2024
Q1
$7.34M Hold
107,729
0.01% 996
2023
Q4
$6.74M Sell
107,729
-4,440
-4% -$245K 0.01% 1016
2023
Q3
$5.09M Buy
112,169
+6,207
+6% +$321K ﹤0.01% 1063
2023
Q2
$5.95M Hold
105,962
0.01% 1030
2023
Q1
$4.79M Sell
105,962
-28,915
-21% -$1.4M ﹤0.01% 1086
2022
Q4
$5.48M Sell
134,877
-12,783
-9% -$678K ﹤0.01% 1088
2022
Q3
$9.65M Buy
147,660
+17,356
+13% +$1.26M 0.01% 883
2022
Q2
$7.92M Sell
130,304
-13,329
-9% -$784K 0.01% 922
2022
Q1
$9.02M Buy
143,633
+9,862
+7% +$619K 0.01% 981
2021
Q4
$10.1M Sell
133,771
-4,562
-3% -$399K 0.01% 974
2021
Q3
$15.5M Buy
138,333
+1,072
+0.8% +$135K 0.01% 773
2021
Q2
$22.2M Sell
137,261
-10,534
-7% -$1.28M 0.02% 645
2021
Q1
$18M Buy
147,795
+6,226
+4% +$940K 0.01% 738
2020
Q4
$21.7M Buy
141,569
+19,166
+16% +$2.27M 0.02% 626
2020
Q3
$10.2M Buy
122,403
+18,600
+18% +$1.65M 0.01% 835
2020
Q2
$7.63M Buy
103,803
+73,478
+242% +$4.3M 0.01% 960
2020
Q1
$1.29M Buy
30,325
+1,400
+5% +$72.3K ﹤0.01% 1855
2019
Q4
$1.76M Buy
28,925
+11,725
+68% +$640K ﹤0.01% 2099
2019
Q3
$705K Buy
17,200
+3,300
+24% +$158K ﹤0.01% 2440
2019
Q2
$655K Sell
13,900
-56,600
-80% -$2.26M ﹤0.01% 2403
2019
Q1
$2.52M Sell
70,500
-2,057
-3% -$71.1K ﹤0.01% 1625
2018
Q4
$2.07M Buy
72,557
+48,174
+198% +$1.67M ﹤0.01% 1710
2018
Q3
$1.08M Buy
24,383
+6,589
+37% +$345K ﹤0.01% 2285
2018
Q2
$1.05M Buy
+17,794
New +$1.01M ﹤0.01% 2304

Other funds holding CRSP